Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA refuse-to-file letter
Biotech
Moderna hit with FDA refusal-to-file letter for mRNA flu shot
The FDA specifically took issue with the trial's control arm, which incorporated a "licensed standard-dose seasonal influenza vaccine," Moderna said.
Eric Sagonowsky
Feb 10, 2026 7:45pm
FDA refuses Axsome filing for former Pfizer fibromyalgia asset
Jun 9, 2025 12:27pm
Soligenix stock sinks as FDA refuses lymphoma application
Feb 14, 2023 10:15am
BrainStorm shares tumble as FDA again knocks back ALS drug
Nov 10, 2022 10:05am
FDA refuses to review Aeglea's rare disease drug application
Jun 2, 2022 3:49pm
Plot twist: FDA pivots on Alkermes' depression drug
Apr 16, 2018 6:02pm